Clinical Trial: A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients

U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07404202) titled 'A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumor Patients' on Feb. 05.

Brief Summary: This is a multicenter, non-interventional, descriptive study to retrospectively collect solid tumor samples from focused tumor types (NSCLC, GYN cancers, BTC and UC) and assess both assay concordance and interpretation concordance.

Study Start Date: March 12

Study Type: OBSERVATIONAL

Condition: Pan-tumor(NSCLC, GYN Cancers, BTC and UC)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: AstraZeneca

Disclaimer: Curated by HT Syndication....